Literature DB >> 19793334

Association of the -31C/T functional polymorphism in the interleukin-1beta gene with the intractability of Graves' disease and the proportion of T helper type 17 cells.

F Hayashi1, M Watanabe, T Nanba, N Inoue, T Akamizu, Y Iwatani.   

Abstract

Interleukin (IL)-1beta is a proinflammatory cytokine and has been implicated in the pathogenesis of several autoimmune diseases. To evaluate the hypothesis that the functional -31C/T polymorphism (rs1143627) in the gene encoding IL-1beta is associated with the intractability and the severity of autoimmune thyroid diseases, we genotyped this polymorphism in 64 patients with intractable Graves' disease (GD), 28 GD patients in remission, 49 patients with Hashimoto's disease (HD) who developed hypothyroidism (severe HD), 28 untreated euthyroid HD patients (mild HD) and 59 healthy volunteers. The -31T allele, which is related to the high producibility of IL-1beta, was significantly more frequent in patients with intractable GD than in those with GD in remission (P = 0.0017; odds ratio 2.8; 95% confidence interval 1.5-5.3), although there was no difference in this frequency between two groups of HD patients. We showed additionally that the proportion of IL-17-producing T helper type 17 (Th17) cells, whose differentiation and proliferation are promoted by IL-1beta, was higher in autoimmune thyroid disease patients with the T allele than in those with CC genotypes. In conclusion, our data indicated that the T allele of -31C/T polymorphism in the IL1B gene was involved in the intractability of GD, and this involvement may arise through the differentiation and proliferation of Th17 cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19793334      PMCID: PMC2792823          DOI: 10.1111/j.1365-2249.2009.04034.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  36 in total

1.  IL-1 enhances T cell-dependent antibody production through induction of CD40 ligand and OX40 on T cells.

Authors:  S Nakae; M Asano; R Horai; N Sakaguchi; Y Iwakura
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

2.  Cytokine gene polymorphisms in autoimmune thyroid disease.

Authors:  P J Hunt; S E Marshall; A P Weetman; J I Bell; J A Wass; K I Welsh
Journal:  J Clin Endocrinol Metab       Date:  2000-05       Impact factor: 5.958

Review 3.  Regulation of IL-17 production in human lymphocytes.

Authors:  Zhi Chen; John J O'Shea
Journal:  Cytokine       Date:  2007-11-05       Impact factor: 3.861

4.  Polymorphisms of IL-1 beta gene in Japanese patients with Sjögren's syndrome and systemic lupus erythematosus.

Authors:  Yoshifumi Muraki; Akito Tsutsumi; Reiko Takahashi; Eiji Suzuki; Taichi Hayashi; Yusuke Chino; Daisuke Goto; Isao Matsumoto; Hideyuki Murata; Emiko Noguchi; Takayuki Sumida
Journal:  J Rheumatol       Date:  2004-04       Impact factor: 4.666

5.  B cell chemoattractant CXCL13 is preferentially expressed by human Th17 cell clones.

Authors:  Rie Takagi; Takehiro Higashi; Kumiko Hashimoto; Kazuhisa Nakano; Yosuke Mizuno; Yasushi Okazaki; Sho Matsushita
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

6.  IL-21 and TGF-beta are required for differentiation of human T(H)17 cells.

Authors:  Li Yang; David E Anderson; Clare Baecher-Allan; William D Hastings; Estelle Bettelli; Mohamed Oukka; Vijay K Kuchroo; David A Hafler
Journal:  Nature       Date:  2008-05-11       Impact factor: 49.962

7.  The +869T/C polymorphism in the transforming growth factor-beta1 gene is associated with the severity and intractability of autoimmune thyroid disease.

Authors:  H Yamada; M Watanabe; T Nanba; T Akamizu; Y Iwatani
Journal:  Clin Exp Immunol       Date:  2008-01-08       Impact factor: 4.330

8.  Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease.

Authors:  Takashi Nanba; Mikio Watanabe; Naoya Inoue; Yoshinori Iwatani
Journal:  Thyroid       Date:  2009-05       Impact factor: 6.568

9.  Involvement of functional polymorphisms in the TNFA gene in the pathogenesis of autoimmune thyroid diseases and production of anti-thyrotropin receptor antibody.

Authors:  N Inoue; M Watanabe; T Nanba; M Wada; T Akamizu; Y Iwatani
Journal:  Clin Exp Immunol       Date:  2009-01-22       Impact factor: 4.330

10.  Interleukin (IL)-1 gene polymorphisms: relevance of disease severity associated alleles with IL-1beta and IL-1ra production in multiple sclerosis.

Authors:  Hans M Schrijver; Jaco van As; J Bart A Crusius; Christien D Dijkstra; Bernard M J Uitdehaag
Journal:  Mediators Inflamm       Date:  2003-04       Impact factor: 4.711

View more
  19 in total

1.  Associations between autoimmune thyroid disease prognosis and functional polymorphisms of susceptibility genes, CTLA4, PTPN22, CD40, FCRL3, and ZFAT, previously revealed in genome-wide association studies.

Authors:  Naoya Inoue; Mikio Watanabe; Hiroya Yamada; Kazuya Takemura; Fumiaki Hayashi; Noriko Yamakawa; Maiko Akahane; Yu Shimizuishi; Yoh Hidaka; Yoshinori Iwatani
Journal:  J Clin Immunol       Date:  2012-06-17       Impact factor: 8.317

2.  Candidate SNP markers of aggressiveness-related complications and comorbidities of genetic diseases are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters.

Authors:  Irina V Chadaeva; Mikhail P Ponomarenko; Dmitry A Rasskazov; Ekaterina B Sharypova; Elena V Kashina; Marina Yu Matveeva; Tatjana V Arshinova; Petr M Ponomarenko; Olga V Arkova; Natalia P Bondar; Ludmila K Savinkova; Nikolay A Kolchanov
Journal:  BMC Genomics       Date:  2016-12-28       Impact factor: 3.969

Review 3.  T regulatory (Treg) and T helper 17 (Th17) lymphocytes in thyroid autoimmunity.

Authors:  Roberto González-Amaro; Mónica Marazuela
Journal:  Endocrine       Date:  2015-10-16       Impact factor: 3.633

4.  The functional polymorphisms of VDR, GC and CYP2R1 are involved in the pathogenesis of autoimmune thyroid diseases.

Authors:  N Inoue; M Watanabe; N Ishido; Y Katsumata; T Kagawa; Y Hidaka; Y Iwatani
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

5.  Association of functional polymorphisms in promoter regions of IL5, IL6 and IL13 genes with development and prognosis of autoimmune thyroid diseases.

Authors:  N Inoue; M Watanabe; M Morita; K Tatusmi; Y Hidaka; T Akamizu; Y Iwatani
Journal:  Clin Exp Immunol       Date:  2011-01-14       Impact factor: 4.330

6.  Association of functional GITR gene polymorphisms related to expression of glucocorticoid-induced tumour necrosis factor-receptor (GITR) molecules with prognosis of autoimmune thyroid disease.

Authors:  R Tomizawa; M Watanabe; N Inoue; K Takemura; Y Hidaka; T Akamizu; K Hayakawa; Y Iwatani
Journal:  Clin Exp Immunol       Date:  2011-05-19       Impact factor: 4.330

Review 7.  Psoriasis and Systemic Inflammatory Disorders.

Authors:  Tomoko Tashiro; Yu Sawada
Journal:  Int J Mol Sci       Date:  2022-04-18       Impact factor: 6.208

8.  Association of polymorphisms in DNMT1, DNMT3A, DNMT3B, MTHFR and MTRR genes with global DNA methylation levels and prognosis of autoimmune thyroid disease.

Authors:  Y Arakawa; M Watanabe; N Inoue; M Sarumaru; Y Hidaka; Y Iwatani
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

9.  High salt intake does not exacerbate murine autoimmune thyroiditis.

Authors:  P Kolypetri; E Randell; B N Van Vliet; G Carayanniotis
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

10.  A high frequency of circulating th22 and th17 cells in patients with new onset graves' disease.

Authors:  Di Peng; Bingchuan Xu; Ye Wang; Hui Guo; Yanfang Jiang
Journal:  PLoS One       Date:  2013-07-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.